Millennium Management’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Millennium Management's OCDX Position: Q2 2022 in Review
Millennium Management sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 518,275 shares — an estimated $9.7M sold.
Millennium Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $17.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Millennium Management reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Millennium Management sold 518,275 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $9.7M.
- Millennium Management first reported a position in Ortho Clinical Diagnostics Holdings in Q2 2021 and held it in 4 quarters.
- Millennium Management's Ortho Clinical Diagnostics Holdings position peaked at $17.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.